Medical Fish Skin Company Kerecis Limited Completes $16 Million Series C Offering

ARLINGTON, Va. and REYKJAVIK, Iceland, June 13, 2019 -- (Healthcare Sales & Marketing Network) -- Kerecis Limited, the company pioneering the use of fish skin in tissue regeneration, has completed a $16 million Series C funding round. The company sold sha... Regenerative Medicine, Wound Care, Venture Capital Kerecis, fish skin, Omega3 Wound, Omega3 Burn
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news